Premium
Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis
Author(s) -
Martinez Olivia M.,
Villanueva Janeth C.,
Gershwin M. Eric,
Krams Sheri M.
Publication year - 1995
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.1840210120
Subject(s) - primary biliary cirrhosis , cytotoxic t cell , granzyme b , immunology , autoimmune hepatitis , cytokine , biology , ctl* , perforin , hepatitis , immune system , t cell , cd8 , biochemistry , in vitro
Abstract Primary biliary cirrhosis (PBC) is an autoimmune disease of the liver with unknown etiology. Autoreactive T lymphocytes that infiltrate the liver may play a major role in the bile duct damage that accompanies the disease. We hypothesized that cytokines produced by T lymphocytes and other cells are central to the disease process. Therefore, we used reverse transcription‐polymerase chain reaction (PCR) and Southern hybridization to identify cytokine message directly from liver tissue of 11 patients with PBC and 5 patients with autoimmune hepatitis (AI‐CAH). Messenger RNA (mRNA) for interleukin (IL)‐2, IL‐5, IL‐6, interferon gamma (IFN‐γ), and transforming growth factor beta (TGF‐β) were detected in the majority of the specimens from patients with PBC. The presence of IL‐5 was associated with PBC ( P <.001, PBC vs. AI‐CAH). Because IL‐5 is a potent eosinophil differentiation factor, we looked for evidence of activated eosinophils within the infiltrate. We observed the deposition of the primary cytotoxic granule protein of eosinophils, major basic protein (MBP), within the portal region of livers from patients with PBC. Moreover, we detected message for a cytotoxic T‐lymphocyte (CTL) granzyme in 87.5% of these livers indicating that mature CTL are present. Thus, we present evidence for two effector pathways that may contribute to the tissue damage observed in PBC and have identified massage for cytokines that may regulate these pathways. (Hepatology 1995;21:113–119).